Page 13 - Génome Québec - 2016-2017 Annual Report

FINANCIAL ACTIVITY REPORT

Génome Québec receives most of its financial support from the Québec government and Genome Canada
for the funding of research projects and the operation of its technology centres.

As of March 31, 2017, our research portfolio includes General and administrative expenses, business develop-
58 research projects, while three technology centres ment and communications and committee expenses
are currently in operation. Génome Québec invested amounted to $2.9 million, a decrease of $570,382
$52.3 million during the 2016-2017 fiscal year. This compared to last fiscal year. After certain adjustments,
amount, combined with the $36.1 million invested by these expenses represent 3.3% of total investments for
other partners, brings our overall injection of funds to the year. Investment and intellectual property revenues
$88.4 million, an increase of 2.8% over last year. reached $162,326, for a return of 1.16%.
Business volume generated by research projects during The excess of revenue over expenses totalling $687,700
this fiscal year amounted to $64.8 million. The most is the combined effect of the surplus of $685,373
important activities are from the Genomics and generated by the technology centres, the investment
Personalized Health competition and the Fonds de and intellectual property revenues of $162,326 dollars,
partenariat pour un Québec innovant et en santé. This minus the insufficiency resulting from the general
year, new projects from the Natural Resources and the and administrative expenses of $158,806, and from
Environment, the Disruptive Innovation in Genomics activities carried out without government funding of
and the Bioinformatics and Computational Biology $1,193. Non-designated net assets were up $626,439,
competitions were launched. The budget for projects reaching a total of $2.7 million on March 31, 2017. Net
underway totals $349 million, $113 million of which is assets dedicated to activities decreased by $145,905
still to be carried out. during the fiscal year and represent a net balance of
$74,587. Net assets totalling $735,096 have once again
For the year ended on March 31, 2017, sales arising from been earmarked for the contingency and technological
the technology centres totalled $16.5 million, down development funds.
3.9% compared to last year. However, the technology
centres posted an excess of revenues over expenses Finally, Génome Québec has respected the terms and
of $685,373 compared to an insufficiency of $555,351 conditions in compliance with the contractual agree-
from the previous fiscal year. ments it has signed with its major financial partners.

DANIEL CODERRE CLAUDE LAMARRE
PRESIDENT AND CEO, VICE PRESIDENT, FINANCE
GÉNOME QUÉBEC GÉNOME QUÉBEC

ANNUAL REPORT 2016-17 13